IMS/ PMSI
Thursday, 1 April 1999
Featured In: April / May 1999 (Vol. 2 Iss. 2)
The UK Monopolies and Mergers Commission recently ruled that the merger between pharmaceutical business information firms IMS Health INC and Pharmaceutical Marketing Services INC (PMSI) could reduce competition in pharmaceutical data services, and required IMS to divest the Source Dispenser business and to give undertakings in relation to supplying these services.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to April / May 1999 (Vol. 2 Iss. 2)
Back to top